Related Experiment Video
Updated: May 10, 2025

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
6.5K
Adverse Health Outcomes Associated with Hypoglycemia Following Bariatric Surgery
Yang Yu1, Qianheng Ma2, Adnin Zaman3
1School of Nursing, University of Rochester, Rochester, New York, USA.
Metabolic Syndrome and Related Disorders
|April 23, 2025
Summary
Hypoglycemia after bariatric surgery negatively impacts mental health and quality of life. Increased frequency and severity of hypoglycemia worsen depressive symptoms and reduce work productivity.
Area of Science:
- Metabolic Surgery
- Endocrinology
- Psychosomatic Medicine
Background:
- Hypoglycemia is a common complication following bariatric surgery.
- The long-term clinical significance of post-bariatric hypoglycemia remains incompletely understood.
Purpose of the Study:
- To investigate the longitudinal associations between hypoglycemia and mental health, quality of life, work productivity, and weight loss.
- To analyze how hypoglycemia occurrence, frequency, severity, and symptoms relate to patient outcomes over 84 months post-surgery.
Main Methods:
- Secondary analysis of data from the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study.
- Self-reported data on hypoglycemia, depressive symptoms, quality of life, and work productivity.
- Objective weight measurements and linear mixed-effects modeling with time-lagged analyses.
Main Results:
- Hypoglycemia affected 20-30% of participants over 84 months.
- Hypoglycemia was linked to increased depressive symptoms and decreased physical and mental quality of life.
- Greater hypoglycemia frequency and severity exacerbated negative associations with quality of life and work productivity domains.
Conclusions:
- Hypoglycemia significantly impacts the physical and psychosocial well-being of patients post-bariatric surgery.
- Further research with enhanced hypoglycemia measurement and broader outcome assessments is warranted.
Related Concept Videos
Hypoglycemia and Glucagon
138
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
138
Oral Hypoglycemic Agents: Biguanides and Glitazones
136
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
136
Diabetes: Symptoms, Diagnosis, and Complications
475
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
475
Pathophysiology of Diabetes
807
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
807
Insulin: Dosing Regimen and Adverse Effects
125
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
125
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K

